Markets

Tuesday 3/13 Insider Buying Report: DLTR, CRVS

Shutterstock photo
Shutterstock photo

Shutterstock photo

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

On Friday, Dollar Tree ( DLTR )'s Director, Conrad M. Hall, made a $918,281 buy of DLTR, purchasing 10,000 shares at a cost of $91.83 a piece. Hall was up about 4.0% on the buy at the high point of today's trading session, with DLTR trading as high as $95.47 at last check today. Dollar Tree is trading up about 0.7% on the day Tuesday. Before this latest buy, Hall bought DLTR at 2 other times during the past year, for a total cost of $683,200 at an average of $68.32 per share.

And on Monday, CEO Richard A. Miller, M.D. bought $850,000 worth of Corvus Pharmaceuticals ( CRVS ), buying 100,000 shares at a cost of $8.50 each. Before this latest buy, Miller, M.D. purchased CRVS on 2 other occasions during the past year, for a total investment of $354,934 at an average of $10.14 per share. Corvus Pharmaceuticals is trading up about 3% on the day Tuesday. Miller, M.D. was up about 22.9% on the buy at the high point of today's trading session, with CRVS trading as high as $10.45 in trading on Tuesday.

VIDEO: Tuesday 3/13 Insider Buying Report: DLTR, CRVS

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CRVS DLTR

Latest Markets Videos

    BNK Invest

    BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

    Learn More